Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$2.94
+0.100 (+3.52%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $2.63 $3.11 Thursday, 9th May 2024 ABUS stock ended at $2.94. This is 3.52% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 5.36% from a day low at $2.80 to a day high of $2.95.
90 days $2.30 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Dec 14, 2022 $2.67 $2.79 $2.62 $2.72 1 182 910
Dec 13, 2022 $2.71 $2.81 $2.60 $2.67 877 664
Dec 12, 2022 $2.61 $2.77 $2.59 $2.71 667 697
Dec 09, 2022 $2.72 $2.73 $2.61 $2.61 648 296
Dec 08, 2022 $2.58 $2.75 $2.56 $2.72 737 856
Dec 07, 2022 $2.46 $2.61 $2.46 $2.57 546 255
Dec 06, 2022 $2.44 $2.55 $2.42 $2.45 958 410
Dec 05, 2022 $2.45 $2.55 $2.38 $2.43 519 967
Dec 02, 2022 $2.30 $2.51 $2.26 $2.48 1 012 764
Dec 01, 2022 $2.37 $2.45 $2.30 $2.33 1 192 009
Nov 30, 2022 $2.40 $2.49 $2.31 $2.35 1 376 575
Nov 29, 2022 $2.56 $2.64 $2.39 $2.39 1 035 412
Nov 28, 2022 $2.66 $2.74 $2.53 $2.58 1 105 464
Nov 25, 2022 $2.71 $2.71 $2.66 $2.67 151 547
Nov 23, 2022 $2.66 $2.80 $2.66 $2.70 635 979
Nov 22, 2022 $2.68 $2.71 $2.64 $2.66 411 478
Nov 21, 2022 $2.77 $2.83 $2.62 $2.64 840 081
Nov 18, 2022 $2.87 $2.87 $2.73 $2.84 931 367
Nov 17, 2022 $2.68 $2.89 $2.64 $2.79 1 094 533
Nov 16, 2022 $2.85 $2.91 $2.70 $2.71 1 313 581
Nov 15, 2022 $2.70 $2.84 $2.64 $2.76 1 288 250
Nov 14, 2022 $2.55 $2.69 $2.49 $2.69 924 337
Nov 11, 2022 $2.48 $2.64 $2.43 $2.56 603 633
Nov 10, 2022 $2.50 $2.51 $2.35 $2.47 850 567
Nov 09, 2022 $2.34 $2.56 $2.33 $2.43 469 129
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT